Late-Breaking Clinical Trials
Submission Deadline: Thursday, January 28, 2021, 1:00 p.m. ET.
The submission process for ACC.21 Late-Breaking Clinical Trials is now closed.
Join us for ACC.21 for cutting-edge science.
Late-Breaking Clinical Trials were accepted in the following categories:
- Major Study
- Smaller Study/Randomized Clinical Trial
- Multi-center Observational Study or Registry
- Secondary Analysis of Major Clinical Trial
Accepted Late-Breaking Clinical Trial submissions will be streamed live during ACC.21, the all virtual experience! Three LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM). Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA and NEJM. In addition, each LBCT session will be followed by a press conference with top media outlets.
| 2021 American College of Cardiology Foundation. Visit ACC.org|